CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 23 enrolled
Drug / intervention
Gamma Tocopherol 700 mg capsules, +1 moredrug
Likely dose
Gamma Tocopherol 700 mg capsules,from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02104505
NCT02104505Phase 2Completed
CompareCT.gov

Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled LPS

University of North Carolina, Chapel Hill·interventional·Posted Apr 4, 2014·Updated Nov 6, 2017

In Brief

A Phase 2 clinical trial evaluating Gamma Tocopherol 700 mg capsules, and Placebo for Mild, Allergic Asthma. Completed, enrolled 23 participants across 1 site.

Detailed Summary

To test the hypothesis that gamma tocopherol (vitamin E) supplement inhibits endotoxin induced airways inflammation in allergic asthmatics

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMild, Allergic Asthma
CountriesUnited States
CollaboratorsNational Institute of Environmental Health Sciences (NIEHS), Purdue University

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 4, 2014
Enrollment StartNov 1, 2015
Primary CompletionSep 1, 2016
Study CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 12.2 years ago

Interventions

Gamma Tocopherol 700 mg capsules,drug

2 capsules daily

Placebodrug

Safflower oil capsules